HemostOD is a seed financed start-up developing in-vitro human platelets. It has 10 staff, 8 of which are based at laboratories on the EPFL Innovation park in Lausanne. With operations commencing in 2021, HemostOD's next milestone is a pre-IND meeting in 2026 and commencement of IND studies.

Location

Additional address info

  • EPFL Innovation Park, Batiment M

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2020
  • Number of employees in Switzerland
    1-9

Key business

Keep browsing

You may also be interested in